Immunic (NASDAQ:IMUX) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December [Yahoo! Finance]
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December
Immunic (NASDAQ:IMUX) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
Immunic (NASDAQ:IMUX) had its price target lowered by analysts at HC Wainwright from $10.00 to $8.00. They now have a "buy" rating on the stock.